EHA 2025: Real-World Insights on Belantamab Mafodotin in RRMM
/ Fredrik Schjesvold
AML Insights – June Update: What’s New in the Field
/ Jan Andreasen
Nordic AML Insights – June Update: Research and EHA Congress
/ Jan Andreasen
EHA 2025: Overcoming Venetoclax Resistance
/ Justinas Daraskevicius
Several Options for Frontline Treatment of MCL
/ Mats Jerkeman